Evidence map›Paper›PMID 42096452›Full record

ArticlePLOS global public health2026

Evaluation and estimation of epidemic trajectories for SARS-CoV-2 from clinical and wastewater data in Gauteng Province, South Africa.

Zinhle E Mthombothi, Adrian Lison, Fiona Els, Cari van Schalkwyk, Leon Danon, Gillian Maree, Jeremy L Bingham, Sipho Gwala, Victor Mabasa, Natasha Singh and 9 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zinhle E MthombothiSouth African Centre for Epidemiological Modelling and Analysis (SACEMA), Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-0078-1260
Adrian LisonDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID https://orcid.org/0000-0002-6822-8437
Fiona ElsGauteng City-Region Observatory (GCRO), a Partnership of the University of Johannesburg, the University of the Witwatersrand, the Gauteng Provincial Government and Organised Local Government in Gauteng (SALGA), Johannesburg, Gauteng, South Africa.ORCID https://orcid.org/0000-0002-4169-813X
Cari van SchalkwykSouth African Centre for Epidemiological Modelling and Analysis (SACEMA), Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa.
Leon DanonDepartment of Engineering Mathematics, University of Bristol, Bristol, United Kingdom.
Gillian MareeGauteng City-Region Observatory (GCRO), a Partnership of the University of Johannesburg, the University of the Witwatersrand, the Gauteng Provincial Government and Organised Local Government in Gauteng (SALGA), Johannesburg, Gauteng, South Africa.ORCID https://orcid.org/0000-0002-7952-6659
Jeremy L BinghamSouth African Centre for Epidemiological Modelling and Analysis (SACEMA), Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-0523-9518
Sipho GwalaCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Victor MabasaCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.ORCID https://orcid.org/0000-0002-0564-0344
Natasha SinghCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Emmanuel PhalaneCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Mokgaetji MachekeCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Said RachidaCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Nkosenhle NdlovuCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Chenoa SankarCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Sibonginkosi MaposaCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Mukhlid YousifCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Kerrigan McCarthyCentre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa.
Kathleen M O'ReillyCentre for Mathematical Modelling of Infectious Diseases, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inferring epidemic trajectories of viral infections from wastewater data can be a useful addition to clinical-based surveillance, as it provides low cost, population-level data that includes both symptomatic and asymptomatic individuals who contribute to the sewer system. However, methods for analyzing wastewater data have been primarily applied to high-resource settings. It remains an open question to what extent epidemic dynamics can also be estimated from wastewater data in low-resource settings, where measurements are less frequent and the underlying catchment population is not clearly characterized. We used SARS-CoV-2 wastewater data from the Gauteng Province in South Africa (June 2021 to March 2022). We used the R packages EpiSewer and EpiNow2 to estimate the effective reproduction number (Rt) from wastewater data and geographically matched clinical surveillance data, respectively. The comparison between wastewater and clinical Rt showed that the observed trends are not perfectly aligned. Despite these differences, wastewater and clinical Rt estimates identified similar transmission patterns, which were similar to the trend seen directly from the recorded data. Maximum wastewater Rt of 1.38 (95% CI: 1.17-1.44) was observed in early November 2021, whilst clinical Rt was 1.18 (90% CI: 0.85-1.27) in June 2021. The change in Rt aligned with an increase or decrease in recorded cases. Our findings demonstrate that, even with limited data, estimating epidemic trajectories is feasible, providing valuable insights for informing public health recommendations. However, whenever possible, we recommend using wastewater surveillance as a complementary tool for clinical surveillance.

Identifiers

PMID42096452
PMCPMC13152178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.